These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3234728)

  • 1. [Leuko- and thrombocytopenic reactions of the body to the intravenous administration of emulsions of perfluoro-organic compounds].
    Sedova LA; Berkos MV; Piatovskaia NN
    Gematol Transfuziol; 1988 Nov; 33(11):45-8. PubMed ID: 3234728
    [No Abstract]   [Full Text] [Related]  

  • 2. Side reaction caused by the perfluorocarbon emulsions in intravenous infusion to experimental animals.
    Sedova LA; Kochetygov NI; Berkos MV; Pjatowskaja NN
    Artif Cells Blood Substit Immobil Biotechnol; 1998 Mar; 26(2):149-57. PubMed ID: 9564433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of the rabbit lung as a criterion of safety for fluorocarbon breathing and blood substitutes.
    Clark LC; Hoffmann RE; Davis SL
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):1085-99. PubMed ID: 1391430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative histological studies in an experiment on the action of different perfluoro-organic compounds].
    Glasko EN; Loginova LN; Khokhlova MP
    Gematol Transfuziol; 1983 Apr; 28(4):49-52. PubMed ID: 6852514
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of some mitochondrial functions following liver perfusion with perfluorotributylamine emulsions.
    Branca D; Scutari G; Siliprandi N; Vincenti E; Gambaretto G
    Biochem Pharmacol; 1988 Jun; 37(12):2479-81. PubMed ID: 3390210
    [No Abstract]   [Full Text] [Related]  

  • 6. Magnetometric measurements of macrophage activity in the liver after administration of different perfluorochemicals.
    Koester MB; Lutz J
    Adv Exp Med Biol; 1994; 345():215-20. PubMed ID: 8079710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocompatibility of synthetic oxygen carriers and fluorosurfactants.
    Northoff H; Haidmann L; Hänsch G; Reuter P; Mader J; Meinert H
    Infusionsther Transfusionsmed; 1992 Jun; 19(3):115-6, 119-20. PubMed ID: 1498551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of perfluoroorganic emulsions on hematological indicators in laboratory animals].
    Sedova LA; Piatovskaia NN
    Gematol Transfuziol; 1985 Feb; 30(2):35-7. PubMed ID: 3979792
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of fluorocarbon emulsion on the cardiovascular system].
    Chen WZ; Li HQ; Shen YT; Dong YL; Ding XC
    Yao Xue Xue Bao; 1986 Feb; 21(2):86-91. PubMed ID: 3751596
    [No Abstract]   [Full Text] [Related]  

  • 10. [Oxygen supply of the body during the administration organofluorine emulsions (a pathophysiological analysis)].
    Iarochkin VS; Koziner VB
    Patol Fiziol Eksp Ter; 1988; (3):81-6. PubMed ID: 3050820
    [No Abstract]   [Full Text] [Related]  

  • 11. Complement Activation-Related Pathophysiological Changes in Anesthetized Rats: Activator-Dependent Variations of Symptoms and Mediators of Pseudoallergy.
    Dézsi L; Mészáros T; Őrfi E; Fülöp TG; Hennies M; Rosivall L; Hamar P; Szebeni J; Szénási G
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31505853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood coagulation after the infusion of emulsions of perfluoroorganic compounds].
    Panchenko SM
    Gematol Transfuziol; 1986 Sep; 31(9):32-4. PubMed ID: 3533706
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of a perfluoro-organic emulsion on bone marrow function in rats].
    Sedova LA; Piatovskaia NN; Rakhmankulova LD
    Gematol Transfuziol; 1985 Sep; 30(9):39-41. PubMed ID: 4054570
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of Fluosol-DA on the reticuloendothelial system function in surgical patients.
    Fujita T; Suzuki C; Ogawa R
    Prog Clin Biol Res; 1983; 122():265-72. PubMed ID: 6878369
    [No Abstract]   [Full Text] [Related]  

  • 15. [Elimination of perfluoro-organic compounds from rat organs].
    Aprosin IuD; Sidliarov DP; Rybolovlev IuR; Shushina LV; Afonin NI
    Gematol Transfuziol; 1983 Apr; 28(4):44-9. PubMed ID: 6852513
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biophysical mechanisms of toxicity of fluorocarbon emulsions].
    Obratsov VV; Tarakhovskiĭ IuS; Ponomarchuk VV; Sklifas AN
    Biofizika; 1994; 39(4):732-7. PubMed ID: 7981282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microemulsions of perfluorinated and semi-fluorinated compounds.
    Lattes A; Rico-Lattes I
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1007-18. PubMed ID: 7849905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitation of complement activation by perfluorocarbon emulsions: superiority of lecithin-emulsified preparations.
    Hammerschmidt DE; Vercellotti GM
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):431-8. PubMed ID: 3263156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative evaluation of the thromboelastogram indices in in vitro research on emulsions of perfluoro-organic compounds].
    Panchenko SM; Afonin NI; Sidliarov DP; Pavlova-Verevkina OB
    Gematol Transfuziol; 1987 Jul; 32(7):50-3. PubMed ID: 3666392
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety studies of modified hemoglobin as an oxygen-carrying blood substitute.
    Chang TM
    Hematol Pathol; 1993; 7(1):49-55. PubMed ID: 8468266
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.